UCB Pharma

UCB Pharma is the UK subsidiary of UCB S.A., a Belgian biopharmaceutical company focused on the discovery and development of treatments for severe neurological and immunological diseases.

The UK operation is one of UCB's three global R&D hubs, with capabilities spanning antibody discovery, small molecule development, targeted protein degradation, and early manufacturing.

Therapeutic programmes address epilepsy, Parkinson's disease, inflammatory conditions, and rare diseases.